Market Access Management & Consulting

Market access services for pharmaceutical and biotech companies regarding European HTA and legislation, reimbursement, pricing and negotiation. 
Interim management (director level).

"I work at the interface between strategic consulting and operational implementation of market access processes. My strength lies in transferring clinical study designs into HTA processes in European countries (comparators, endpoints etc.) and optimizing pricing outcomes under challenging initial conditions." 
Carolin Knorr-Hendreich

Carolin Knorr-Hendreich

Principal Consultant, Owner

I am a market access professional with more than 16 years of experience in consultancy and international biotech and pharmaceutical companies. My clients profit from in-depth experience in strategic market access management and operational implementation. I advise clinical-stage companies regarding European market access processes and pricing and I support the launch of new therapeutic agents. I have proven competence in multiple indications, particularly in rare diseases, oncology, immunology, cardiovascular, neurology and genetic disorders. To the benefit of my customers I have a broad network and a sound expertise in preparation of HTA processes throughout Europe as well as in preparation and execution of effective negotiation and contracting strategies with payers. I am a Political Scientist (Master of Arts, University of Heidelberg) and hold a postgraduate degree in Market Access Management (EBS University of Business and Law, EBS European Business School, Wiesbaden/Oestrich-Winkel). Additionally, I am a certified Qualified Negotiator (Schranner Negotiation Institute, Zurich).